LP demand seen driving Chinese healthcare buyouts
Investors are looking beyond venture capital funds to gain exposure to Chinese healthcare, but the market needs more local management expertise, industry professionals say.
Limited partners (LPs) invested in early- or late-stage venture capital healthcare funds in China are driving demand for buyout opportunities in the sector in order to eke out additional gains.
The claim comes after a report this month by Bain & Company described 2018 as a “banner year” for healthcare buyouts in the Asia Pacific region, with 88 deals worth a disclosed total of $15.8 billion recorded.
Dennis Kwan, managing director, MVision Private Equity Advisers, said LPs w…
Please sign in or register
for free access to 1 article per month from AsianInvestor’s content and archives of over 16,000 articles.
¬ Haymarket Media Limited. All rights reserved.